Back to results
US 2021/0330696 A1Published application
A high capacity platform for immunogenic cancer cell death
OwnerRita Elena Serda, Achraf Noureddoneinventors
Life of this patent
Estimating the term…
Abstract
Compositions comprising, and methods of using, mesoporous hybrid siliceous nanoparticles comprising a TLR ligand or other immune stimulant(s), and an agent to induce immunogenic cell death.
Claims27
A mesoporous hybrid siliceous nanoparticle comprising an immune stimulant and an agent to induce immunogenic cell death (ICD).
(canceled)
6-8. (canceled)
11-12. (canceled)
16-18. (canceled)
20-27. (canceled)
(canceled)
39-40. (canceled)
Dependencies are inferred from the claim text.